Last week, Michael Wiggins, co-founder of CKc and Chairman of the Board, met with one of our funded researchers, Dr. Mario Otto, at the University of Wisconsin. Michael toured their Children’s Hospital and Medical Sciences facility and met with Dr. Otto to discuss the progress of CKc’s clinical trial grant, awarded in honor of Trevor Scheerer in 2016, involving novel immunotherapy stem cell transplant therapy for rhabdomyosarcoma. They also discussed future research opportunities, funding Young Investigators, and the collaboration and sharing of data among pediatric cancer researchers. CKc is pursuing novel, alternative approaches to treat childhood cancer. Funding innovative research is our mission!